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Abstract
Background: The routine removal of orthopaedic fixation devices after fracture healing remains
an issue of debate. There are no evidence-based guidelines on this matter, and little is known on
surgeons' practice and perceived effectiveness of implant removal in different clinical settings.
Methods: A 41-item questionnaire was distributed to 730 attendees of the AO Principles and
Masters Courses of Operative Fracture Treatment in Davos, Switzerland, to assess their attitudes
towards removal of different types of implants, and perceived benefits and risks with this common
procedure.
Results: The response rate was 655/730 (89.7%), representing 54.6% of all 1199 course attendees.
Surgeons from 65 countries (571 males and 84 females, mean age 39 ± SD 9 years) took part in the
survey. Fifty-eight percent of the participants did not agree that routine implant removal is
necessary, and 49% and 58% did not agree that indwelling implants pose an excess risk for fractures
or general adverse effects. Forty-eight percent felt that removal is riskier than leaving the implant
in situ. Implant removal in symptomatic patients was rated to be moderately effective (mean rating
on a 10-point-scale, 5.8, 95% confidence interval 5.7–6.0). Eighty-five percent of all participants
agreed that implant removal poses a burden to hospital resources. Surgeons were undetermined
whether implant removal is adequately reimbursed by payers of health care services (44% "I-don't-
know"-answers).
Conclusion: Many surgeons refuse a routine implant removal policy, and do not believe in
clinically significant adverse effects of retained metal implants. Given the frequency of the
procedure in orthopaedic departments worldwide, there is an urgent need for a large randomized
trial to determine the efficacy and effectiveness of implant removal with regard to patient-centred
outcomes.
Background
Implant removal belongs to the most common elective
orthopaedic procedures in the industrial countries. In a
frequently cited Finnish study, implant removal contrib-
uted to almost 30% of all planned orthopaedic opera-
tions, and 15% of all operations of the department [1].
Controversy exists as to the need for routine implant
removal. In children, it may be necessary to remove
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implants early to avoid disturbances to the growing skele-
ton, to prevent their bony immuring making later removal
technically difficult or impossible, and to allow for
planned reconstructive surgery after skeletal maturation
(e.g., in case of hip dysplasia).
In adults, pain, soft tissue irritation, the resumption of
strenuous activities or contact sports after fracture healing,
and the patient's demand are typical indications for
implant removal in clinical practice. Many surgeons will
remember patients whose intractable, hardly explainable
local symptoms and complaints resolved quickly after the
procedure. However, implant removal requires a second
surgical procedure in scarred tissue, and poses a risk for
nerve damage and re-fractures [2-5].
Pain may even worsen after implant removal. In a series of
109 femoral nail removals, an increase in pain and dis-
comfort was noted in 4/58 (7%) of all patients with, and
10/51 (20%) of all patients without pre-operative symp-
toms [6]. Similar observations were made in subjects who
had undergone open reduction and internal fixation of
ankle fractures [7].
Corrosion, systemic release of nickel, chromium, and
cobalt, and its presumed toxic, allergic, and even carcino-
genic potential have been linked to stainless steel
implants. As yet, none of these adverse effects had con-
vincingly been confirmed in the clinical setting [8].
Orthopedic fixation devices made from titanium alloy are
considered less susceptible to degradation and safe to be
retained in situ [9,10], but titanium and aluminum had
been traced in serum and hair of 16 of 46 patients after
spinal instrumentation as well [11].
Little is known on the attitudes of orthopedic surgeons
towards implant removal [12,13]. We reasoned that a
questionnaire survey may be an appropriate method to
evaluate surgeons' perceptions about the need, effective-
ness, and risks of this common procedure in different clin-
ical settings.
Methods
We developed a three-page questionnaire with 41 items to
determine surgeons' opinions and concerns about
implant removal. As a first step, DS undertook a literature
review in Pubmed Medline, Embase, SciSearch, and
Google to identify available instruments assessing sur-
geons' beliefs and assumptions about implant removal
and other common orthopedic procedures. We consid-
ered the items queried by Loder et al. in a recent web sur-
vey pragmatic and relevant for this study, and used them
as a core set [12]. We then followed a sample-to-redun-
dancy strategy to compile a comprehensive set of items
describing the baseline profile of participants, potential
confounders, and relevant endpoints [14-16]. The prelim-
inary version of the questionnaire was emailed between
the authors, who added, deleted, and revised individual
items and questions until consensus was reached. The
final version of the instrument was reviewed by three clin-
ical experts (see acknowledgments), who felt comfortable
with its overall extent, scope of questions, and scaling of
possible answers.
The form contained three parts: 1) demographic informa-
tion (including age, gender, level of training and speciali-
zation, current affiliation, and origin), 2) general beliefs
about potential benefits and harms of retained material
and removal surgery, and 3) reasons for removing
implants (e.g., type of implant, clinical conditions
demanding removal).
We requested participants to describe their practice of
informing patients about the need for later implant
removal at the time of fracture repair, and to estimate the
influence of removal surgery on patients' complaints.
Because cold welding may cause problems when attempt-
ing to remove interlocking plates, surgeons were asked
how often they observe screw breakages, irremovable
implant, and fractures with this frequently used material.
Table 1: Demographic profile of the respondents.
Characteristic
Mean age, years (SD) 38.8 (9.3)
Median age, years (range) 36 (26 – 71)
Gender
Male 571 (87.2%)
Female 84 (12.8%)
Professional background
General surgeon 96 (14.7%)
Orthopedic surgeon 361 (55.2%)
Trainee 121 (18.5%)
Spine surgeon 7 (1.1%)
Other 69 (10.6%)
Affiliation
University hospital 277 (42.3%)
Public, non-university hospital 303 (46.3%)
Private hospital 61 (9.3%)
Other 14 (2.1%)
Current position
Chief of staff 128 (20.0%)
Consultant 174 (27.1%)
Intern/resident 215 (33.5%)
Other 124 (19.3%)
Origin
Africa 29 (4.5%)
Asia 58 (9.0%)
Australia 8 (1.2%)
Europe 470 (72.9%)
North America 38 (5.9%)
South America 42 (6.5%)BMC Musculoskeletal Disorders 2008, 9:73 http://www.biomedcentral.com/1471-2474/9/73
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General beliefs were polled by 5-point Likert-scales.
Answer options included "I strongly agree," "I strongly
disagree," "I don't know," "I disagree," and "I strongly dis-
agree." For all other questions, ratings were made on 10-
point scales ranging from "1 = never" to "10 = always."
The survey was conducted during the last three days of the
first, and the first three days of the second course week. A
booth was established at the main entrance hall of the
conference venue to allow participants for completing the
questionnaire in a quiet and comfortable surrounding.
Assistants addressed course attendants personally and
invited them to participate in the survey. Also, posters
were put up at main meeting places and the industrial
exhibition explaining the goal of the study. As an incen-
tive, all respondents took part in a drawing for an iPod®
player.
A consent waiver was granted by the Cantonal Ethics
Board of Zurich. The participants were informed that, by
filling out the questionnaire, they agreed in using the
anonymously gathered data for research and publication.
All analyses were made in an exploratory intent, and we
did not pose a formal null-hypothesis. The target sample
size was planned to yield a certain precision of estimates,
not to detect a relevant difference between groups with
predefined type I and II errors [17]. A sample size of 650
eligible forms guaranteed standard errors ≤5% for propor-
tions (in case of Likert-scale type answers) and continuous
endpoints (i.e., 10-point scales). To compensate for a
drop-out rate of 10%, a total of 730 forms were distrib-
uted during the meeting.
According to the quality of data, results are presented as
proportions, means, or medians with their adequate
measures of distribution and 95% confidence intervals
(CI). For subgroup analyses (i.e., age, gender, profession,
affiliation, origin), Likert-scale type ratings were analyzed
by ordered logistic regression. Ten-point scales were ana-
lyzed by general linear models. To ease reading and data
interpretation, the results from queries on general opin-
ions about implant removal are expressed as proportions
of disagreement (including "I strongly disagree" and "I
disagree") and agreement (including "I strongly agree"
and "I agree").
Results
Of 730 distributed questionnaires, 655 (89.7%) were
completed. This represented 54.6% of all 1199 attendees
of the 2006 AO Principles and Masters Courses. Surgeons
from 65 countries with a mean age of 38.8 ± SD 9.3 years
(range, 26 to 71 years) took part in the survey. There were
571 males and 84 women. The demographic profile is
summarized in Table 1.
Table 2 summarizes the distribution of answers to ques-
tions about general opinions and attitudes. Many sur-
geons did not agree that orthopedic implants need to be
routinely removed in younger, asymptomatic patients
(disagreement: 57.8%, agreement: 37.1%). Also, many
participants did not believe that indwelling implant pose
Table 2: Proportions of agreement and disagreement in statements about general attitudes towards implant removal.
Statement n I strongly 
agree
I agree I don't know I disagree I strongly 
disagree
Orthopedic implants must be removed in younger 
patients (<40 years of age), even if they cause no 
problems
645 39 (6.0%) 
[4.3–8.2%]
200 (31.0%) 
[27.5–34.7%]
33 (5.1%) 
[3.5–7.1%]
297 (46.0%) 
[42.1–50.0%]
76 (11.8%) 
[9.4–14.5%]
Leaving implants in-situ poses a risk for later fractures 645 15 (2.3%) 
[1.3–3.8%]
212 (32.9%) 
[29.3–36.6%]
104 (16.1%) 
[13.4–19.2%]
287 (44.5%) 
[40.6–48.4%]
27 (4.2%) 
[2.8–6.0%]
Titanium implants are safer to be kept in-situ than 
devices made from stainless steel
647 48 (7.4%) 
[5.5–9.7%]
252 (38.9%) 
[35.2–42.8%]
180 (27.8%) 
[24.4–31.4%]
148 (22.9%) 
[19.7–26.3%]
19 (2.9%) 
[1.8–4.5%]
In case of otherwise unexplained pain and functional 
deficits, implant removal is a good option to improve 
the physical status
646 51 (7.9%) 
[5.9–10.2%]
394 (61.0%) 
[57.1–64.8%]
78 (12.1%) 
[9.7–14.8%]
111 (17.2%) 
[14.4–20.3%]
12 (1.9%) 
[1.0–3.2%]
Leaving implants in-situ increases the life-time risk for 
chronic infections, allergy, and cancer
649 15 (2.3%) 
[1.3–3.8%]
107 (16.5%) 
[13.7–19.6%]
150 (23.1%) 
[19.9–26.6%]
310 (47.8%) 
[43.9–51.7%]
67 (10.3%) 
[8.1–12.9%]
Removing implants is a surgical procedure which drains 
valuable hospital resources
644 114 (17.7%) 
[14.8–20.9%]
436 (67.7%) 
[63.9–71.3%]
21 (3.3%) 
[2.0–4.9%]
71 (11.0%) 
[8.7–13.7%]
2 (0.3%) [0.0–
1.1%]
Removing implants damages healed soft tissue, and is 
riskier than retaining the device
643 29 (4.5%) 
[3.0–6.4%]
281 (43.7%) 
[39.8–47.6%]
75 (11.7%) 
[9.3–14.4%]
243 (37.8%) 
[34.0–41.7%]
15 (2.3%) 
[1.3–3.8%]
Given the time and efforts required for implant 
removal, this procedure is not adequately reimbursed 
by insurance companies
642 46 (7.2%) 
[5.3–9.4%]
190 (29.6%) 
[26.1–33.3%]
285 (44.4%) 
[40.5–48.3%]
112 (17.4%) 
[14.6–20.6%]
9 (1.4%) [0.6–
2.6%]
Patients should take responsibility for the incurring 
costs of implant removal
642 15 (2.3%) 
[1.3–3.8%]
109 (17.0%) 
[14.2–20.1%]
91 (14.2%) 
[11.6–17.1%]
328 (51.1%) 
[47.1–55.0%]
99 (15.4%) 
[12.7–18.5%]
n = number of available answers. Percentages in brackets are 95% confidence intervals.BMC Musculoskeletal Disorders 2008, 9:73 http://www.biomedcentral.com/1471-2474/9/73
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an excess risk for fractures (disagreement: 48.7%, agree-
ment: 35.2%) and allergy or malignancy (disagreement:
58.1%, agreement: 18.8%). Titanium was considered
safer to be retained than stainless steel material (disagree-
ment: 25.8%, agreement: 46.4%).
In contrast to the overall tendency against routine metal
removal, 68.9% of all respondents agreed that it repre-
sents a therapeutic option in case of otherwise unex-
plained pain and functional deficits (disagreement:
19.0%). Interestingly, implant removal was considered
only moderately effective in resolving local symptoms
(mean rating 5.8, 95% CI 5.7 – 6.0).
Orthopedic surgeons were less enthusiastic about the
appropriateness of implant removal in case of "sympto-
matic" implant than general surgeons. Both had similar
opinions about the moderate effectiveness of this proce-
dure.
A similar proportion of participants disagreed and agreed
that implant removal causes additional soft tissue damage
(40.1% versus 48.2%).
Most respondents considered implant removal a proce-
dure that drains valuable hospital resources (agreement:
85.4%, disagreement: 11.3%).
Nearly half of all surgeons (44.4%) could not decide
whether implant removal is adequately reimbursed by
health care insurance carriers, and 36.8% and 18.8%
agreed and disagreed that payments are inadequate for the
procedure. However, most surgeons won't charge patients
to pay for implant removal by themselves (disagreement:
66.5%, agreement: 19.3%).
With a mean rating of 8.2 (95% CI 7.9 – 8.4) on a 10-
point-scale, surgeons would recommend the regular
removal of elastic titanium nails in children, followed by
almost identical ratings for cerclage wires after fixation of
fractures of the patella and the elbow (mean rating 7.3,
95% CI 7.1 – 7.5, mean difference 1.5 point, 95% CI 1.3
– 1.7 points, p < 0.0001). Plates at the humeral shaft were
assigned the lowest priority for removal (mean rating 3.4,
95% CI 3.2 – 3.6). Findings are illustrated in Figure 1.
Palpable and irritating material was considered the main
indication for metal removal (mean rating 8.9, 95% CI
8.8 – 9.1), whereas the patient's demand ranked lowest on
the list of potential indications (mean rating 6.8, 95% CI
6.6 – 7.0). Results are depicted in Figure 2.
Surgeons tended towards informing patients about the
need for later implant removal at the time of fracture
repair (mean rating 7.6, 95% CI 7.4 – 7.8).
Participants reported low rates of intra- and post-opera-
tive screw breakages (4.0, 95% CI 3.8 – 4.2), irremovable
implants (3.0, 95% CI 2.9 – 3.2), and re-fractures (2.5,
95% CI 2.3 – 2.6).
Table 3 summarizes the findings from ordered logistic
regression analysis. Older respondents, Europeans, and
university-affiliated surgeons were more likely to agree
that implants must be removed in younger patients. Tita-
nium was considered safer to be retained than stainless
steel by older participants, non-orthopedic surgeons, and
Main indications for implant removal Figure 2
Main indications for implant removal. Mean ratings on 
10-point scales with 95% confidence intervals. Assigned removal priority to different types of implants Figure 1
Assigned removal priority to different types of 
implants. Mean ratings on 10-point scales with 95% confi-
dence intervals.BMC Musculoskeletal Disorders 2008, 9:73 http://www.biomedcentral.com/1471-2474/9/73
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Europeans. Also, non-orthopedic and European surgeons
were more likely to agree that implant removal is a good
therapeutic option to improve pain and function.
Older, male, non-European, and university-based sur-
geons were more likely to agree that implant removal is
inadequately reimbursed by health-care insurers.
Discussion
In 1988, an estimated number of 4.9 million US Ameri-
can citizens had prevalent fixation devices [18]. With
expanding indications for operative fracture treatment in
all age groups and fracture types, it is likely that this
number has substantially increased during the last two
decades.
Table 3: Variables contributing to the likelihood of agreement in the different statements about general attitudes towards implant 
removal.
Statement Surgeons' age Male versus 
female surgeon
Orthopedic ver-
sus non-ortho-
pedic surgeon
European ver-
sus US-Ameri-
can origin
European ver-
sus non-Euro-
pean origin
University ver-
sus other affilia-
tion
Orthopedic implants 
must be removed in 
younger patients (<40 
years of age), even if 
they cause no 
problems
1.03 (1.01–1.04) 1.12 (0.74–1.70) 1.23 (0.92–1.64) 7.40 (3.77–14.50) 1.56 (1.12–2.18) 0.72 (0.54–0.97)
Leaving implants in-situ 
poses a risk for later 
fractures
0.99 (0.98–1.01) 1.32 (0.86–2.02) 1.13 (0.84–1.50) 2.81 (1.44–5.47) 0.98 (0.71–1.35) 0.79 (0.59–1.06)
Titanium implants are 
safer to be kept in-situ 
than devices made 
from stainless steel
1.02 (1.00–1.04) 0.82 (0.54–1.22) 0.72 (0.54–0.96) 2.16 (1.18–3.97) 1.05 (0.76–1.45) 1.04 (0.78–1.38)
In case of otherwise 
unexplained pain and 
functional deficits, 
implant removal is a 
good option to 
improve the physical 
status
1.00 (0.98–1.02) 0.86 (0.53–1.38) 0.73 (0.54–1.00) 2.74 (1.47–5.11) 1.81 (1.28–2.55) 0.83 (0.61–1.13)
Leaving implants in-situ 
increases the life-time 
risk for chronic 
infections, allergy, and 
cancer
1.01 (0.99–1.03) 1.14 (0.74–1.76) 1.26 (0.94–1.68) 1.66 (0.90–3.08) 0.99 (0.72–1.37) 0.92 (0.69–1.22)
Removing implants is a 
surgical procedure 
which drains valuable 
hospital resources
1.00 (0.98–1.02) 1.51 (0.91–2.48) 0.99 (0.72–1.38) 1.39 (0.68–2.84) 1.11 (0.77–1.60) 1.08 (0.78–1.50)
Removing implants 
damages healed soft 
tissue, and is riskier 
than retaining the 
device
0.99 (0.97–1.00) 1.06 (0.69–1.64) 0.91 (0.68–1.22) 1.20 (0.65–2.23) 1.20 (0.65–2.23) 1.36 (1.01–1.82)
Given the time and 
efforts required for 
implant removal, this 
procedure is not 
adequately reimbursed 
by insurance 
companies
1.02 (1.00–1.03) 1.41 (0.93–2.14) 1.43 (1.07–1.91) 0.37 (0.19–0.70) 0.37 (0.19–0.70) 1.25 (0.93–1.67)
Patients should take 
responsibility for the 
incurring costs of 
implant removal
1.03 (1.01–1.05) 2.39 (1.52–3.76) 1.61 (1.20–2.16) 0.48 (0.26–0.91) 0.24 (0.17–0.34) 1.31 (0.98–1.75)
Numbers are odds ratios derived from ordered logistic regression, with 95% confidence intervals in parentheses. Values >1 indicate a higher 
likelihood of agreement, and values <1 indicate a higher likelihood in disagreement. If the 95% confidence limits exclude 1, statistically significant 
results can be assumed at the two-tailed 5% threshold.BMC Musculoskeletal Disorders 2008, 9:73 http://www.biomedcentral.com/1471-2474/9/73
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The findings from this survey indicate that about 60% of
all surgeons do not agree in a routine removal policy in
asymptomatic subjects, and that the patient's request is
the less important reason to remove material. Many sur-
geons doubt clinically significant adverse effects of ind-
welling metal like stress shielding or an allergic or even
carcinogenic potential [19-22], and acknowledge the bur-
den of implant removal to hospital resources.
While there are absolute (e.g., cartilage damage by intra-
articular screws, skin and soft tissue irritation by promi-
nent material) and relative indications to take out implant
(e.g., to reduce artifacts with planned MRI and CT imag-
ing), the discrepancy between physical findings, imaging
results and complaints can be remarkable. Given the
apparently quick and safe removal procedure, many sur-
geons may be tempted to take their patients to the operat-
ing theatre instead of conservative management or
watchful waiting.
There is currently no controlled trial that would allow for
a valid trade-off between the benefits and harms of
implant removal, and scientifically grounded counseling
of patients. In addition to the possibility of retained mate-
rial and another period of sick leave and restricted weight
bearing, patients must be informed about potential risks
of the removal operation [6,8,23-25]. In a review of 14
studies enrolling 635 patients who underwent removal of
forearm plates, the overall incidence of complications
ranged from 12 to 40% [26]. Iatrogenic nerve injuries
were noted in 2 to 29%, refractures in 2 to 26%, and
wound infections in 5 to 12% of all studies.
According to eight retrospective studies enrolling 346
symptomatic patients (Table 4), the weighted success rate
(i.e., a complete or marked reduction of pain) of implant
removal can be estimated at 78%. On the other hand, the
weighted failure rate (including subjects with worsening
pain) is 22%, or about 1 in 5 patients. In a recent prospec-
tive study of 60 patients, mean pain scale, Short Muscu-
loskeletal Function Assessment (SMFA), and Short Form
36 Physical Component Scores (SF36-PCS) significantly
improved over one year after removal of painful implants
[25]. With 13 different anatomic sites, and a mean in-situ
time ranging from six months to nine years, unspecific
effects of removal surgery may have contributed to the
observed outcomes. The lack of a head-to-head compari-
son in all available studies prohibits conclusive inferences
about a causal relationship between implant removal and
symptom control.
Elastic stable intramedullary nails (ESIN) ranked first
among all implants to be considered for routine removal.
This information may add to results from a recent survey
of 273 pediatric and 99 non-pediatric specialists regarding
implant removal in children [12]. While 64% and 50% of
all respondents recommended removing DCPs after
upper extremity fractures and interlocking nails after fem-
oral shaft fractures, the different scenarios did not offer an
ESIN option. Some authors admitted their inclination to
remove flexible nails in children despite the lack of scien-
tific evidence and the potential risk for refractures [27,28].
Several limits of this investigation merit discussion. First,
as a survey, it can only describe opinions and practice pat-
terns, and does not allow for determining the actual effec-
tiveness of implant removal. Questionnaire surveys are
prone to multiple sources of bias (e.g., socially desired
response bias) [29], and answers of the respondents may
not reflect their true daily behaviour. In addition, recalled
numbers may be incorrect. Recall bias may also have been
introduced by remembering a recent successful or unsuc-
cessful case. Second, European professionals represented
the largest fraction of all respondents, thereby restricting
the external validity of the findings. Third, the survey form
may have missed certain scenarios, and some of the ques-
tions may also be regarded ambiguous or sketchy.
Table 4: Uncontrolled studies of the effectiveness of implant removal in symptomatic patients. Success includes complete or marked 
reduction of pain
Author Year Implant n Success Failure
Richards [30] 1992 various 46 42 91% (79 – 98%) 4 9% (2 – 21%)
Jacobsen [31] 1994 ankle plates 66 49 74% (62 – 84%) 17 26% (16 – 38%)
Court-Brown [32] 1997 intramedullary tibial nails 62 60 97% (88 – 99%) 2 3% (0 – 11%)
Dodenhoff [33] 1997 intramedullary femoral nails 17 11 65% (38 – 86%) 6 35% (14 – 62%)
Keating [34] 1997 intramedullary tibial nails 49 39 80% (66 – 90%) 10 20% (10 – 34%)
Brown [7] 2001 ankle plates 22 11 50% (28 – 72%) 11 50% (28 – 72%)
Gösling [6] 2004 intramedullary femoral nails 58 45 78% (65 – 87%) 13 22% (13 – 35%)
Gösling [24] 2005 intramedullary tibial nails 26 19 73% (52 – 88%) 7 27% (12 – 48%)
Weighted average 346 78% (69 – 88%) 22% (12 – 31%)
Failure includes no change and worsening of symptoms. Summary estimates were derived from random-effects meta-regression analysisBMC Musculoskeletal Disorders 2008, 9:73 http://www.biomedcentral.com/1471-2474/9/73
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We tried hard to cover a broad range of clinical settings,
and to enrol a large and possibly representative sample of
surgeons. Also, the response rate and the number of com-
pleted items make the estimates reliable. Apart from all
design limitations, the findings may point towards a true
public health problem. Since most surgeons are reluctant
in charging patients for the procedure, reimbursement
strategies need to be evaluated and adopted to the sub-
stantial time and effort associated with implant removal
surgery.
Conclusion
There is a serious need to study the biological mechanisms
and clinical determinants of symptomatic implants, and
to develop clinical decision rules that may allow for iden-
tifying patients who will benefit most from implant
removal. A controlled trial that compares removal to
retention is strongly warranted.
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